Story thread · 2 reports / 2 sources
Switzerland-based Octapharma to invest $1.5B on first US facility
manufacturingdive.com · 8d
How the coverage leans
Across 2 sources · syndicated copies counted once
The plasma-derived medicine maker plans to create 1,500 jobs to support one of the state’s largest private biomedical investments.
First report: Switzerland-based Octapharma to invest $1.5B in first US facility — finance.yahoo.com, 8d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.